AtriCure Inc reports results for the quarter ended December 31 - Earnings Summary

AtriCure

12/02/2025 22:02

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 8
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -21
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 23 cents per share. Wall Street expected
results to range from -41 cents to -9 cents per share.
    * Revenue rose 16.6% to $124.28 million from a year ago;
analysts
expected $121.84 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 33
cents​.
    * The company reported a quarterly loss of $15.57 million.
    * AtriCure Inc shares had risen by 35.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AtriCure Inc is
$45.50 
This summary was machine generated from LSEG data February 12 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.23          -0.08          Beat
 Sep. 30 2024      -0.19          -0.17          Beat
 Jun. 30 2024      -0.17          -0.17          Met
 Mar. 31 2024      -0.23          -0.28          Missed